Beneficial effect of TRAIL on HIV burden, without detectable immune consequences

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Shepard, Brett D ^a   De Forni, Davide ^b   McNamara, David R ^a   Foli, Andrea ^c   Rizza, Stacey A ^a   Abraham, Roshini S ^a   Knutson, Keith ^a   Wettstein, Peter J ^a   Lori, Franco ^d   Badley, Andrew D ^a  

^a MAYO CLINIC   (United States)

^b Virostatics s r l   (Italy)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^d Research Institute for Genetic and Human Therapy (RIGHT)   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CYTOKINE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; INTERLEUKIN 10; TNFSF10 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; DILUTION; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; IN VITRO STUDY; LYMPHOCYTE FUNCTION; PERIPHERAL LYMPHOCYTE; VIRUS LOAD; VIRUS REPLICATION; BIOSYNTHESIS; CELL SURVIVAL; DISEASE CARRIER; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; LYMPHOCYTE; REFERENCE VALUE; VIROLOGY;

BOVINAE;

ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CYTOKINES; DISEASE RESERVOIRS; GENE EXPRESSION REGULATION; HIV; HIV INFECTIONS; HUMANS; INTERLEUKIN-10; LYMPHOCYTES; RECOMBINANT PROTEINS; REFERENCE VALUES; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 52449120352     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003096     Document Type: Article

References (24)

1. Lum JJ, Pilon AA, Sanchez-Dardon J, Phenix BN, Kim JE, et al. (2001) Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo21. J Virol 75: 11128-11136.
2. Lum JJ, Schnepple DJ, Nie Z, Sanchez-Dardon J, Mbisa GL, et al. (2004) Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity. J Virol 78: 6033-6042.
3. Herbeuval JP, Nilsson J, Boasso A, Hardy AW, Kruhlak MJ, et al. (2006) Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proc Natl Acad Sci U S A 103: 7000-7005.
4. Herbeuval JP, Shearer GM (2007) HTV-1 immunopathogenesis: how good interferon turns bad. Clin Immunol 123: 121-128.
5. Lum JJ, Schnepple DJ, Badley AD (2005) Acquired T-cell sensitivity to TRAIL mediated killing during HIV infection is regulated by CXCR4-gp120 interactions. Aids 19: 1125-1133.
6. Miura Y, Misawa N, Maeda N, Inagaki Y, Tanaka Y, et al. (2001) Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice. J Exp Med 193: 651-660.
7. Zhang M, Li X, Pang X, Ding L, Wood O, et al. (2001) Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HTV-1 tat. J Biomed Sci 8: 290-296.
8. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, et al. (1996) Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 70: 199-206.
9. Badley AD, Dockrell D, Simpson M, Schur R, Lynch DH, et al. (1997) Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med 185: 55-64.
10. Audige A, Urosevic, M, Schlaepfer E, Walker R, Powell D, et al. (2006) Anti-HIV state but not apoptosis depends on IFN signature in CD4+ T cells. J Immumol 177: 6227-6237.
11. Gibellini D, Re MC, Ponti C, Vitone F, Bon I, et al. (2005) HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: a potential molecular mechanism to escape TRAIL cytotoxicity. J Cell Physiol 203: 547-556.
12. Zheng L, Yang Y, Guocai L, Pauza CD, Salvato MS (2007) HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosis-induced ligand. Intervirology 50: 224-228.
13. Swingler S, Mann AM, Zhou J, Swingler C, Stevenson M (2007) Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog 3: 1281-1290.
14. Chun TW, Engel D, Berrey AM, Shea T, Corey L, et al. (1998) Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A 95: 8860-8873.
15. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, et al. (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278: 1295-1300.
16. Balestrieri E, Grelli S, Matteucci C, Minutolo A, d'Ettorre G, et al. (2007) Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy. J Med Virol 79: 111-117.
17. Gibellini D, Borderi M, De Crignis E, Cicola R, Vescini F, et al. (2007) RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men. J Med Virol 79: 1446-1454.
18. Koschny R, Walczak H, Ganten TM (2007) The promise of TRAIL-potential and risks of a novel anticancer therapy. J Mol Med 85: 923-935.
19. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, et al. (2000) Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6: 564-567.
20. Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, et al. (2001) Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat Med 7: 383-385.
21. Ganten TM, Koschny R, Sykora J, Schulze-Bergkamen H, Buchler P, et al. (2006) Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs. Clin Cancer Res 12: 2640-2646.
22. Sato K, Hida S, Takayanagi H, Yokochi T, Kayagaki N, et al. (2001) Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta. Eur J Immunol 31: 3138-3146.
23. Falschlehner C, Emmerich CH, Geriach B, Walczak H (2007) TRAIL signalling: decisions between life and death. Int J Biochem Cell Biol 39: 1462-1475.
24. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, et al. (1997) Quantification of latent tissue reservoirs and tbtal body viral load in HIV-1 infection. Nature 387: 183-188.